Breat Cancer
Showing 1 - 25 of >10,000
Glycosylated Extracellular Vesicles for Early Diagnosis of
Not yet recruiting
- Breast Cancer
- Blood Sample
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Jun 9, 2022
Breast Cancer Trial in Riyadh (rehabilitation)
Completed
- Breast Cancer
- rehabilitation
-
Riyadh, Saudi ArabiaKFMC
May 19, 2021
Breast Cancer Trial (Nanoxel M, Taxotere, Doxorubicin)
Not yet recruiting
- Breast Cancer
- Nanoxel M
- +3 more
- (no location specified)
Jan 20, 2022
Case-Control Study of Inflammatory Breast Cancer in North Africa
Completed
- Diabetes
-
Cairo, Egypt
- +5 more
Dec 23, 2020
Glabellar Frown Lines Trial in Canada, United States (Botulinum Toxins, Type A)
Completed
- Glabellar Frown Lines
- Botulinum Toxins, Type A
-
Birmingham, Alabama
- +60 more
Jun 16, 2022
Desmoid Tumors, Aggressive Fibromatosis Trial run by the NCI (PF-03084014)
Active, not recruiting
- Desmoid Tumors
- Aggressive Fibromatosis
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 14, 2022
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Recruiting
- Unknown Primary Tumors
- DNA Methylation
-
Guangzhou, Guangdong, ChinaSun Yat-sen university cancer center
Nov 20, 2023
Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta (Manual Acupuncture)
Recruiting
- Gynecologic Cancer
- +3 more
- Manual Acupuncture
-
Jakarta, DKI Jakarta, IndonesiaSuryamin Hung
Oct 4, 2023
Cigarette Smoking-Related Carcinoma, Lung Carcinoma Trial in Philadelphia (Discussion, Media Intervention, Interview)
Recruiting
- Cigarette Smoking-Related Carcinoma
- Lung Carcinoma
- Discussion
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Aug 18, 2023
Malnutrition; Protein, Cancer, Lung, Cancer Cervix Trial in Jakarta (NUTRICAN)
Recruiting
- Malnutrition; Protein
- +2 more
- NUTRICAN
-
Jakarta, IndonesiaPersahabatan Hospital
Nov 7, 2023
Gastric Cancer, Multi-omics, Diagnosis Trial in Hangzhou (Without any intervention)
Active, not recruiting
- Gastric Cancer
- +2 more
- Without any intervention
-
Hangzhou, Zhejiang, ChinaCancer Hospital of the University of Chinese Academy of Sciences
Nov 15, 2023
Total Management of Ovarian Cancer
Not yet recruiting
- Tumor of Female Reproductive System
- Ovarian Cancer
- No intervention
- (no location specified)
Aug 30, 2023
Tissue Resistivity in Breast Cancer Patients
Completed
- Breast Cancer
- Resistivity measurement
-
Mendrisio, SwitzerlandOspedale Regionale di Mendrisio
Dec 11, 2019
Breast Cancer Trial in Beijing (99mTc-MY6349 SPECT/CT scan)
Recruiting
- Breast Cancer
- 99mTc-MY6349 SPECT/CT scan
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
Prostate Cancer Trial in Boston (Precision screening intervention, Usual care)
Not yet recruiting
- Prostate Cancer
- Precision screening intervention
- Usual care
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jun 21, 2023
Cancer Patients Trial (MBSR, health education)
Not yet recruiting
- Cancer Patients
- MBSR
- health education
- (no location specified)
Jul 2, 2023
Arm Exercise Capacity and Maximal Oxygen Consumption With Breast
Not yet recruiting
- Breast Cancer
- +3 more
- Maximal Exercise Capacity, Maximal Oxygen Consumption (VO2max)
-
Ankara, TurkeyHacettepe University
Sep 1, 2023
HPV Associated Anogenital Pathology in Female Patients and
Recruiting
- Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 2, 2023
Uncover Subtypes of Cancer Cachexia, LOTUS-CC Study
Recruiting
- Cancer Cachexia (CC)
-
Urbana, Illinois
- +4 more
Oct 3, 2023
Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)
Not yet recruiting
- Androgen Deprivation Therapy
- Locally Advanced Prostate Cancer
- Relugolix and Enzalutamide
-
Oklahoma City, OklahomaStephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023
Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City
Not yet recruiting
- Stage IIC Prostate Cancer AJCC v8
- +2 more
- Biospecimen Collection
- +9 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 3, 2023
PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only
Not yet recruiting
- PARP Inhibitor for Esophageal Squamous Cell Carcinoma
- Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
- (no location specified)
Sep 24, 2023
Epithelial Ovarian Cancer: A Retrospective Study
Recruiting
- Epithelial Ovarian Cancer
- Hematologic features
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiao Tong University Schoo
Oct 16, 2023